Investing.com -- RBC Capital Markets reaffirmed its bullish stance on this stock after the diabetes technology company delivered stronger-than-expected first-quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE